Severe respiratory adverse events associated with rituximab infusion.
Kamei
Koichi
K
Ito
Shuichi
S
Iijima
Kazumoto
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D008171:Lung Diseases / Q000139:chemically induced*; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D000069283:Rituximab; D055815:Young Adult
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab